Evidence map›Paper›PMID 37834033›Full record

ArticleInternational journal of molecular sciences2023

Evaluation of the Potential Impact of In Silico Humanization on V

Carla Martins, Julien Diharce, Aravindan Arun Nadaradjane, Alexandre G de Brevern

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carla MartinsUniversité Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB, F-75014 Paris, France.ORCID 0000-0002-6232-9034
Julien DiharceUniversité Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB, F-75014 Paris, France.ORCID 0000-0002-6400-927X
Aravindan Arun NadaradjaneUniversité Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB, F-97715 Saint Denis Messag, France.
Alexandre G de BrevernUniversité Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB, F-75014 Paris, France.ORCID 0000-0001-7112-5626

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0005-02Agence Nationale de la Recherche ANR-11-LABX-0051Agence Nationale de la Recherche ANR-18-IDEX-0001Agence Nationale de la Recherche ANR-19-CE17-0021EU-H2020 and Université de la Réunion S3D VHH program, N° SYNERGIE RE0022962Indo-French Centre for the Promotion of Advanced Research 5302-2National Computer Center for Higher Education A0110313007National Computer Center for Higher Education AP010312904PHC CEDRE 47811WMPOE FEDER 2014-20 of the Conseil Régional de La Réunion S3D VHH program, N° SYNERGIE RE0022962
6 · The paper itself

Abstract

Camelids have the peculiarity of having classical antibodies composed of heavy and light chains as well as single-chain antibodies. They have lost their light chains and one heavy-chain domain. This evolutionary feature means that their terminal heavy-chain domain, VH, called V

Indexed as

Camelids, New WorldImmunoglobulin Heavy ChainsAnimalsAntibodiesBiotechnologyHumansAntibodiesImmunoglobulin Heavy Chainsantibodiesframeworksmolecular dynamics simulationsnanobodiessecondary structuresequence structure relationshipstructural alphabet

Identifiers

PMID37834033
PMCPMC10572902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.